chr12-6978348-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_005768.6(LPCAT3):āc.1033G>Cā(p.Val345Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000249 in 1,608,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 31)
Exomes š: 0.0000021 ( 0 hom. )
Consequence
LPCAT3
NM_005768.6 missense
NM_005768.6 missense
Scores
2
5
12
Clinical Significance
Conservation
PhyloP100: 4.26
Genes affected
LPCAT3 (HGNC:30244): (lysophosphatidylcholine acyltransferase 3) Enables 1-acylglycerophosphocholine O-acyltransferase activity; 1-acylglycerophosphoethanolamine O-acyltransferase activity; and 1-acylglycerophosphoserine O-acyltransferase activity. Involved in phosphatidylcholine acyl-chain remodeling; phosphatidylethanolamine acyl-chain remodeling; and phosphatidylserine acyl-chain remodeling. Located in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]
EMG1 (HGNC:16912): (EMG1 N1-specific pseudouridine methyltransferase) This gene encodes an essential, conserved eukaryotic protein that methylates pseudouridine in 18S rRNA. The related protein in yeast is a component of the small subunit processome and is essential for biogenesis of the ribosomal 40S subunit. A mutation in this gene has been associated with Bowen-Conradi syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.34427857).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LPCAT3 | NM_005768.6 | c.1033G>C | p.Val345Leu | missense_variant | 9/13 | ENST00000261407.9 | NP_005759.4 | |
EMG1 | NM_006331.8 | c.*2539C>G | 3_prime_UTR_variant | 6/6 | ENST00000599672.6 | NP_006322.4 | ||
EMG1 | NM_001320049.2 | c.*2539C>G | 3_prime_UTR_variant | 5/5 | NP_001306978.1 | |||
EMG1 | NR_135131.2 | n.632+2970C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LPCAT3 | ENST00000261407.9 | c.1033G>C | p.Val345Leu | missense_variant | 9/13 | 1 | NM_005768.6 | ENSP00000261407.4 | ||
EMG1 | ENST00000599672.6 | c.*2539C>G | 3_prime_UTR_variant | 6/6 | 1 | NM_006331.8 | ENSP00000470560.1 | |||
ENSG00000290146 | ENST00000607161.5 | n.624+2970C>G | intron_variant | 2 | ENSP00000480420.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151862Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
151862
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1456828Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 724198
GnomAD4 exome
AF:
AC:
3
AN:
1456828
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
724198
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151862Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74142
GnomAD4 genome
AF:
AC:
1
AN:
151862
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
74142
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2021 | The c.1033G>C (p.V345L) alteration is located in exon 9 (coding exon 9) of the LPCAT3 gene. This alteration results from a G to C substitution at nucleotide position 1033, causing the valine (V) at amino acid position 345 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
P
Vest4
MutPred
Loss of MoRF binding (P = 0.1328);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at